Clinical Study
Successful Treatment in Children with Hodgkin Lymphoma in Greece; A 20-Year Experience in a Single Institution
Table 5
Prognostic factors for the outcome.
| | Patients | % | % | | | DFS | EFS | OS | DFS | EFS | OS |
| Age (years) | | | | | | | | | 8 | 9 | 15.5 | 77.8 | 66.7 | 100 | ns | ns | ns | 8 | 49 | 84.5 | 91.8 | 89.8 | 98 | Gender | | | | | | | | | Boys | 35 | 60 | 88.6 | 85.7 | 100 | ns | ns | ns | Girls | 23 | 40 | 91.3 | 87 | 95.7 | Stage | | | | | | | | | I | 7 | 12 | 100 | 85.7 | 100 | ns | ns | ns | II | 25 | 43 | 92 | 92 | 96 | III | 15 | 26 | 93.3 | 86.7 | 100 | IV | 11 | 19 | 72.7 | 72.7 | 100 | Histologic subtype | | | | | | | | | Mixed cellularity | 13 | 22 | 92.3 | 92.3 | 100 | ns | ns | ns | Lymphopenic depletion | 1 | 2 | 100 | 100 | 100 | Lymphocytic predominant | 4 | 7 | 75 | 75 | 100 | Nodular sclerosis | 40 | 69 | 90 | 85 | 97.5 | B-symptoms | | | | | | | | | Present | 18 | 31 | 94.4 | 94.4 | 100 | ns | ns | ns | Absent | 40 | 69 | 87.5 | 82.5 | 97.5 | Mediastinum | | | | | | | | | Great widening | 12 | 21 | 91.7 | 83.3 | 100 | ns | ns | ns | Intermediate widening | 33 | 57 | 87.9 | 87.9 | 97 | Normal | 13 | 22 | 92.3 | 84.6 | 100 | White blood cells (103/mm3)* | | | | | | | | | 10.4 | 29 | 51 | 93.1 | 89.7 | 100 | ns | ns | ns | 10.4 | 28 | 49 | 89.3 | 85.7 | 96.4 | Hemoglobin (g/dL)* | | | | | | | | | 11 | 29 | 51 | 89.6 | 82.8 | 96.5 | ns | ns | ns | 11 | 28 | 49 | 92.9 | 92.9 | 100 | ESR (mm 1st h)* | | | | | | | | | 63 | 29 | 51 | 93.1 | 89.7 | 100 | ns | ns | ns | 63 | 28 | 49 | 89.3 | 85.7 | 96.4 |
|
|
*no values for one patient.
|